228 related articles for article (PubMed ID: 9149740)
1. Immunosuppressive therapy: a potential alternative to bone marrow transplantation as initial therapy for acquired severe aplastic anemia in childhood?
Lawlor ER; Anderson RA; Davis JH; Fryer CJ; Pritchard SL; Rogers PC; Wu JK; Schultz KR
J Pediatr Hematol Oncol; 1997; 19(2):115-23. PubMed ID: 9149740
[TBL] [Abstract][Full Text] [Related]
2. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
[TBL] [Abstract][Full Text] [Related]
3. A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy Consortium.
Pulsipher MA; Lehmann LE; Bertuch AA; Sasa G; Olson T; Nakano T; Gilio A; Burroughs LM; Lipton JM; Huang JN; Dickerson K; Bertaina A; Zhuang C; Malsch M; Fleming M; Weller E; Shimamura A; Williams DA
Pediatr Blood Cancer; 2020 Oct; 67(10):e28444. PubMed ID: 32776425
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.
Kojima S; Horibe K; Inaba J; Yoshimi A; Takahashi Y; Kudo K; Kato K; Matsuyama T
Br J Haematol; 2000 Oct; 111(1):321-8. PubMed ID: 11091219
[TBL] [Abstract][Full Text] [Related]
5. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
[TBL] [Abstract][Full Text] [Related]
6. A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution.
Ellis RJ; Kahn Q; Skikne BS; Mayo MS; Allgood JW; Bodensteiner DM; Deauna-Limayo D; Cook JD
Mil Med; 2002 Jul; 167(7):541-5. PubMed ID: 12125844
[TBL] [Abstract][Full Text] [Related]
7. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
8. Decision analysis of allogeneic bone marrow transplantation versus immunosuppressive therapy for young adult patients with aplastic anemia.
Kanda Y; Usuki K; Inagaki M; Ohta A; Ogasawara Y; Obara N; Kako S; Kurokawa M; Shimada N; Suzuki T; Hama A; Yamaguchi H; Nakao S; Yamazaki H
Int J Hematol; 2023 May; 117(5):660-668. PubMed ID: 36595144
[TBL] [Abstract][Full Text] [Related]
9. Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.
Crump M; Larratt LM; Maki E; Curtis JE; Minden MD; Meharchand JM; Lipton JH; Messner HA
Am J Med; 1992 Jun; 92(6):596-602. PubMed ID: 1605140
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation for acquired aplastic anemia.
Georges GE; Storb R
Curr Opin Hematol; 2016 Nov; 23(6):495-500. PubMed ID: 27607445
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic bone marrow transplantation for severe aplastic anemia: the Hong Kong scenario.
Au WY; Lie AK; Kwong YL; Chan TK; Chim CS; Lee CK; Chiu EK; Liang R
Hematol Oncol; 1998 Jun; 16(2):41-6. PubMed ID: 10065111
[TBL] [Abstract][Full Text] [Related]
12. Treatment strategies for patients with severe aplastic anemia.
Bacigalupo A
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S42-S44. PubMed ID: 18724299
[TBL] [Abstract][Full Text] [Related]
13. Outcome of pediatric acquired aplastic anemia: a developing world experience.
Ramzan M; Yadav SP; Zafar MS; Dinand V; Sachdeva A
Pediatr Hematol Oncol; 2014 Feb; 31(1):29-38. PubMed ID: 23802844
[TBL] [Abstract][Full Text] [Related]
14. Single institution outcomes of treatment of severe aplastic anaemia.
Mollee P; Woodward N; Durrant S; Lockwood L; Gillett EA; Morton J; Rowell J
Intern Med J; 2001 Aug; 31(6):337-42. PubMed ID: 11529587
[TBL] [Abstract][Full Text] [Related]
15. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
16. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
Doney K; Leisenring W; Storb R; Appelbaum FR
Ann Intern Med; 1997 Jan; 126(2):107-15. PubMed ID: 9005744
[TBL] [Abstract][Full Text] [Related]
17. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
[TBL] [Abstract][Full Text] [Related]
18. Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy.
Arranz R; Otero MJ; Ramos R; Steegmann JL; Lamana ML; Tomás JF; de la Cámara R; Figuera A; Vázquez L; Fernádez-Rañada JM
Bone Marrow Transplant; 1994 Apr; 13(4):383-7. PubMed ID: 8019461
[TBL] [Abstract][Full Text] [Related]
19. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
[TBL] [Abstract][Full Text] [Related]
20. Antithymocyte immunoglobulin in severe aplastic anemia and bone marrow transplantation.
Colby C; Stoukides CA; Spitzer TR
Ann Pharmacother; 1996 Oct; 30(10):1164-74. PubMed ID: 8893124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]